Metropolis Healthcare jumps 9% as Q4 profit multiplies

NEW DELHI: Metropolis Healthcare shares jumped as much as 11 per cent on Friday after the company reported a manifold rise in the net profit for the quarter ended March 2021.

Net profit of the diagnostics firm rose 296 per cent to Rs 61.3 crore in the fourth quarter of the last financial year as against Rs 15.5 crore in the corresponding period a year ago. Sales rose 40.95 per cent to Rs 291.73 crore in the quarter ended March 2021, compared to Rs 206.97 crore in the corresponding quarter a year ago.

The scrip jumped 11 per cent to Rs 2,557.45 but gave up some gains to trade at Rs 2,543.85 at noon. It sharply outperformed the benchmark S&P BSE Sensex index, which was up 0.49 per cent at 51,366.32.


In the fourth quarter of FY21, the company recorded its highest ever quarterly revenue largely led by a healthy recovery in non-Covid and increased Covid testing on a month-on-month basis. The company has taken various cost control initiatives to optimise its cost structure leading to enhanced margins in the quarter.

Metropolis Healthcare reported a rise of 44 per cent in net profit to Rs 183.3 crore for the fiscal ended March 31, 2021, compared to the net profit of Rs 127.5 crore in the previous financial year. Sales grew 17 per cent to Rs 997.8 crore from Rs 855.5 crore during the period under review.

Metropolis healthcare was listed in April 2019. Since then, its stock has tripled over the issue price of Rs 877.

The board of Metropolis Healthcare at its meeting held on May 27 approved the appointment of Hemant Sachdev as additional non-executive, non-independent director.